Abstract CN80
Background
Voice loss is a serious problem following surgery for head and neck cancer. Several voice substitutes are available for patients who have undergone laryngectomy; however, none can completely reproduce the original voice and vocal behaviour. Opting in or out for a substitute voice is a decision the patient makes. This study aimed to determine differences in vocal preference and communicative adaptation with and without a substitute voice.
Methods
This prospective observational study used 156 patients who underwent laryngectomy at a cancer hospital in Aichi Prefecture between April 2013 and September 2021. Based on responses from a questionnaire, voice preference and communication adaptation status were assessed, and differences in scores between the substitute voice group and the written communication-only group were analysed. The survey period was from December 2022 to January 2023.
Results
Fifty-seven (62.6%) patients were in the substitute voice group, and 34 (37.4%) were in the written communication-only group. Among the substitute voice group, 28 (49.1%) mainly used an electric larynx. The social life score of the communication adaptation status subscale was significantly (p<.001) higher for the substitute voice group (mean±standard deviation [SD] 15.71±6.49) compared to the written communication-only group (10.23±5.52). In addition, communication confidence scores trended higher (p=.066) in the substitute voice group (10.45±5.67) compared to the written communication-only group (8.03±4.53). In contrast, the preference for vocal actions, a subscale of voice preference, trended higher (p=.055) in the written communication-only group (20.7±2.95) compared to the substitute voice group (18.68±5.10).
Conclusions
In Japan, approximately one-third of patients with head and neck cancer who have undergone laryngectomy live without a voice. Patients who communicated through written means tended to dislike voice substitutions due to desiring a more natural vocalisation. However, written communicators were less adapted to communication than those with voice substitutes. Multidisciplinary support is important for these patients to regain their voice.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
M. Iwai.
Funding
SGH Foundation.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN58 - Canadian resources and strategies to build global oncology nursing excellence
Presenter: Gayatre Maharaj
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN62 - Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: A retrospective cohort study on 18877 patients
Presenter: Yingxue Liu
Session: EONS Poster Display session
Resources:
Abstract
CN63 - Quality of life among parents of children with cancer
Presenter: Abeer Hussain
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN74 - Exploring the correlation between spiritual health, quality of survival, and meaning of life among breast cancer chemotherapy patients
Presenter: Fang Zhao
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN75 - Telehealth interventions and functional outcomes in breast cancer rehabilitation: A systematic review
Presenter: Marco Invernizzi
Session: EONS Poster Display session
Resources:
Abstract
CN76 - A study of sexual dysfunction in Moroccan female survivors of gynaecological cancer: A prospective study about 220 patients
Presenter: Chadia Ezzouitina
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN77 - ‘Eating with others’: Planning, developing and testing a self-management intervention to promote social eating for patients living with and beyond head and neck cancer
Presenter: Mark Dornan
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN79 - Quality-of-Life (QoL) data published by clinical trials supporting drug approvals for renal cell carcinoma (RCC)
Presenter: Rowanne Seadon
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN81 - How to use a theoretical framework to inform intervention development in a breast cancer study?
Presenter: Sek Ying Chair
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN93 - Quality of life scale-based machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer
Presenter: Juanyan Shen
Session: EONS Poster Display session
Resources:
Abstract
Slides